Flu vaccine study for organ transplant patients
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a special flu vaccine, designed for a future pandemic, works safely in people who have had an organ transplant. It aims to find a better way to protect transplant patients from severe flu.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and it has been more than 3 months since your organ transplant.
- Your transplant is working well, with good kidney function (eGFR above 30).
- You have not had a life-threatening reaction to the flu vaccine before, like Guillain-Barré syndrome.
- You have not been treated for transplant rejection, a serious infection, or had a fever in the last 30 days.
- You have not received the flu shot in the last 6 weeks, and you haven't had the flu in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
This trial tests whether a higher dose of flu vaccine works better than the standard dose for people who have had a lung transplant. It may help improve protection against seasonal flu while monitoring safety.
This study compares a high-dose flu vaccine to the standard dose in lung transplant recipients. It aims to see if a higher dose gives better protection against the flu.
This study tests an experimental flu vaccine designed to protect against the H5N8 bird flu virus. It is given with an ingredient that may boost the immune response. The study will check if the vaccine is safe and how well it triggers the body's defenses.
This study tests a vaccine strategy for people who are being evaluated and waiting for a liver transplant. The goal is to see how well the immune system responds and how the results are interpreted before transplant.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
Hear when a new Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.